↓ Skip to main content

Vaccine Design

Overview of attention for book
Cover of 'Vaccine Design'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Immunological and Formulation Design Considerations for Subunit Vaccines
  3. Altmetric Badge
    Chapter 2 Public Health Implications of Emerging Vaccine Technologies
  4. Altmetric Badge
    Chapter 3 Preclinical Safety Assessment Considerations in Vaccine Development
  5. Altmetric Badge
    Chapter 4 Regulatory Considerations in Vaccine Design
  6. Altmetric Badge
    Chapter 5 Clinical Considerations in Vaccine Trials with Special Reference to Candidate HIV Vaccines
  7. Altmetric Badge
    Chapter 6 Laboratory Empiricism, Clinical Design, and Social Value
  8. Altmetric Badge
    Chapter 7 A Compendium of Vaccine Adjuvants and Excipients
  9. Altmetric Badge
    Chapter 8 Adjuvant Properties of Aluminum and Calcium Compounds
  10. Altmetric Badge
    Chapter 9 Structure and Properties of Aluminum-Containing Adjuvants
  11. Altmetric Badge
    Chapter 10 MF59 Design and Evaluation of a Safe and Potent Adjuvant for Human Vaccines
  12. Altmetric Badge
    Chapter 11 Development of Vaccines Based on Formulations Containing Nonionic Block Copolymers
  13. Altmetric Badge
    Chapter 12 Development of an Emulsion-Based Muramyl Dipeptide Adjuvant Formulation for Vaccines
  14. Altmetric Badge
    Chapter 13 Liposomal Presentation of Antigens for Human Vaccines
  15. Altmetric Badge
    Chapter 14 Liposome Design and Vaccine Development
  16. Altmetric Badge
    Chapter 15 Lipid Matrix-Based Vaccines for Mucosal and Systemic Immunization
  17. Altmetric Badge
    Chapter 16 Polymer Microspheres for Vaccine Delivery
  18. Altmetric Badge
    Chapter 17 Vehicles for Oral Immunization
  19. Altmetric Badge
    Chapter 18 Design and Production of Single-Immunization Vaccines Using Polylactide Polyglycolide Microsphere Systems
  20. Altmetric Badge
    Chapter 19 Nanoparticles as Adjuvants for Vaccines
  21. Altmetric Badge
    Chapter 20 Water-Soluble Phosphazene Polymers for Parenteral and Mucosal Vaccine Delivery
  22. Altmetric Badge
    Chapter 21 Monophosphoryl Lipid A as an Adjuvant
  23. Altmetric Badge
    Chapter 22 Structural and Immunological Characterization of the Vaccine Adjuvant QS-21
  24. Altmetric Badge
    Chapter 23 A Novel Generation of Viral Vaccines Based on the ISCOM Matrix
  25. Altmetric Badge
    Chapter 24 Vaccine Adjuvants Based on Gamma Inulin
  26. Altmetric Badge
    Chapter 25 A New Approach to Vaccine Adjuvants
  27. Altmetric Badge
    Chapter 26 Stearyl Tyrosine
  28. Altmetric Badge
    Chapter 27 Cytokines as Vaccine Adjuvants
  29. Altmetric Badge
    Chapter 28 Cytokines as Immunological Adjuvants
  30. Altmetric Badge
    Chapter 29 Cytokine-Containing Liposomes as Adjuvants for Subunit Vaccines
  31. Altmetric Badge
    Chapter 30 Haemophilus influenzae Type b Conjugate Vaccines
  32. Altmetric Badge
    Chapter 31 Pneumococcal Conjugate Vaccines
  33. Altmetric Badge
    Chapter 32 Lyme Vaccine Enhancement
  34. Altmetric Badge
    Chapter 33 Vaccine Research and Development for the Prevention of Filarial Nematode Infections
  35. Altmetric Badge
    Chapter 34 Retrovirus and Retrotransposon Particles as Antigen Presentation and Delivery Systems
  36. Altmetric Badge
    Chapter 35 Rationale and Approaches to Constructing Preerythrocytic Malaria Vaccines
  37. Altmetric Badge
    Chapter 36 The MAP System
  38. Altmetric Badge
    Chapter 37 Design of Experimental Synthetic Peptide Immunogens for Prevention of HIV-1 and HTLV-I Retroviral Infections
  39. Altmetric Badge
    Chapter 38 Design and Testing of Peptide-Based Cytotoxic T-Cell-Mediated Immunotherapeutics to Treat Infectious Diseases and Cancer
  40. Altmetric Badge
    Chapter 39 Development of Active Specific Immunotherapeutic Agents Based on Cancer-Associated Mucins
  41. Altmetric Badge
    Chapter 40 Synthetic Peptide Vaccines for Schistosomiasis
  42. Altmetric Badge
    Chapter 41 Synthetic Hormone/Growth Factor Subunit Vaccine with Application to Antifertility and Cancer
Attention for Chapter 10: MF59 Design and Evaluation of a Safe and Potent Adjuvant for Human Vaccines
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)

Mentioned by

wikipedia
1 Wikipedia page

Citations

dimensions_citation
98 Dimensions

Readers on

mendeley
61 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
MF59 Design and Evaluation of a Safe and Potent Adjuvant for Human Vaccines
Chapter number 10
Book title
Vaccine Design
Published in
Pharmaceutical biotechnology, January 1995
DOI 10.1007/978-1-4615-1823-5_10
Pubmed ID
Book ISBNs
978-1-4613-5737-7, 978-1-4615-1823-5
Authors

Gary Ott, Gail L. Barchfeld, David Chernoff, Ramachandran Radhakrishnan, Peter van Hoogevest, Gary Van Nest, Ott, Gary, Barchfeld, Gail L., Chernoff, David, Radhakrishnan, Ramachandran, van Hoogevest, Peter, Van Nest, Gary, Hoogevest, Peter, Nest, Gary

Editors

Michael F. Powell, Mark J. Newman

Mendeley readers

The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 3%
United States 1 2%
Italy 1 2%
Brazil 1 2%
Unknown 56 92%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 16 26%
Researcher 13 21%
Student > Bachelor 6 10%
Student > Doctoral Student 6 10%
Student > Master 4 7%
Other 5 8%
Unknown 11 18%
Readers by discipline Count As %
Agricultural and Biological Sciences 14 23%
Immunology and Microbiology 9 15%
Pharmacology, Toxicology and Pharmaceutical Science 7 11%
Biochemistry, Genetics and Molecular Biology 6 10%
Medicine and Dentistry 6 10%
Other 7 11%
Unknown 12 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 April 2020.
All research outputs
#5,966,050
of 18,304,658 outputs
Outputs from Pharmaceutical biotechnology
#2
of 8 outputs
Outputs of similar age
#141,263
of 401,450 outputs
Outputs of similar age from Pharmaceutical biotechnology
#1
of 1 outputs
Altmetric has tracked 18,304,658 research outputs across all sources so far. This one is in the 46th percentile – i.e., 46% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8 research outputs from this source. They receive a mean Attention Score of 2.5. This one scored the same or higher as 6 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 401,450 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them